Alison S. Long's most recent trade in Taysha Gene Therapies Inc was a trade of 113,246 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Taysha Gene Therapies Inc | Alison S. Long | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 113,246 | 113,246 | - | - | Stock Option (right to buy) | |
| Taysha Gene Therapies Inc | Alison S. Long | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 56,623 | 105,843 | - | 0 | Common Stock | |
| Taysha Gene Therapies Inc | Alison S. Long | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 98,440 | 98,440 | - | - | Stock Option (right to buy) | |
| Taysha Gene Therapies Inc | Alison S. Long | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 49,220 | 49,220 | - | 0 | Common Stock | |
| Taysha Gene Therapies Inc | Alison S. Long | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2023 | 43,800 | 43,800 | - | - | Stock Option (right to buy) |